[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017 US Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs-Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review

November 2016 | 241 pages | ID: 2F976F453B5EN
Venture Planning Group

US$ 3,120.00 US$ 3,900.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.

The report presents a detailed analysis of the Hepatitis diagnostics market in the US.
  • Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
    • Hospitals
    • Commercial/Private Labs
    • Blood Banks
    • Physician Offices
    • Public Health Labs
    In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.

    Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

    Contains 241 pages and 14 tables
  • I. INTRODUCTION

    II. HEPATITIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

    A. Background
    B. Hepatitis A
    C. Hepatitis B
    D. Hepatitis C
      Classification
      Transmission of Infection
      Occupational Hazards
      Acute Hepatitis
      Diagnosis of Acute Infection
      Chronic Hepatitis
      HCV and Other Chronic Liver Diseases
      Alcoholic Liver Disease
      Hepatitis B Coinfection
      Cirrhosis and Hepatocellular Carcinoma
      Diagnostic Tests
      Possible Indications for HCV RNA Testing
      Conclusions and Future Direction
    E. Hepatitis D
      Historical Perspective
      Epidemiology
      HBV-HDV 'Coinfection' vs. 'Superinfection'
      Methods of Detecting HDV
      Prevention
    F. Hepatitis E
      Background
      Prevalence of the Disease
      Diagnostic Tests
      Epidemiologic Serosurveys
      Serologic Cross-Reactivity
    G. Hepatitis G
      Vaccines and Drugs
    H. Review of Leading Analyzers Marketed by: Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
    I. Emerging Diagnostic Technologies
      1. Molecular Diagnostics
      2. Monoclonal Antibodies
      3. Immunoassays
      4. Differential Light Scattering
      5. Information Technology
      6. Artificial Intelligence
      7. Liposomes
      8. Flow Cytometry
      9. Chromatography
      10. Diagnostic Imaging
      11. Gel Microdroplets
      12. Other

    III. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

    X. ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for Decentralized Testing Markets
      1. Marketing Approaches
      2. Product Complexity
      3. Customer Preference
      4. Established Suppliers
      5. Emerging Suppliers
      6. Major Types of Distributors
      7. Market Segmentation

    XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    XII. COMPETITIVE ASSESSMENTS

    Abbott
    Affymetrix
    Beckman Coulter/Danaher
    Becton Dickinson
    bioMerieux
    Bio-Rad
    Cepheid
    Diamedix/Erba
    DiaSorin
    Eiken Chemical
    Elitech Group
    Enzo Biochem
    Fujirebio
    Grifols
    Hologic/Gen-Probe
    ID Biomedical/GSK
    Kreatech/Leica
    Lonza
    Ortho-Clinical Diagnostics
    Qiagen
    Roche
    Scienion
    Sequenom
    SeraCare
    Siemens
    Takara Bio
    Thermo Fisher
    Wallac/PE
    Wako

    LIST OF TABLES

    Major Companies Developing or Marketing Hepatitis Tests
    U.S.A HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S.A HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S.A. HBs Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S.A. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S.A. Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S.A. Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S.A. Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S.A. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S.A. HBc Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S.A. HBe Ag Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S.A. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
    U.S.A. Hepatitis C Testing Market Diagnostics Sales by Major Supplier


    More Publications